Abbott Laboratories Reports Strong Q2, Beating EPS and Revenue Forecasts

Abbott Laboratories (NYSE: ABT) reported sales of $10.4 billion in the second quarter of 2024, reflecting a 4.0% increase from the same period last year. source: https://tokenist.com/abbott-laboratories-reports-strong-q2-beating-eps-and-revenue-forecasts/?utm_source=rss&utm_medium=rss&utm_campaign=abbott-laboratories-reports-strong-q2-beating-eps-and-revenue-forecasts